Literature DB >> 11993318

Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages.

G R Burgio1, A G Ugazio, L Nespoli, A F Marcioni, A M Bottelli, F Pasquali.   

Abstract

Immunologic studies were performed in 83 patients with Down's Syndrome (DS) in ages ranging from a few months to 30 years and 76 karyotypically normal age-matched controls. The results show that both thymus-dependent and independent functions were impaired in DS with a characteristic age sequence. Serum immunoglobulin levels were normal in children with DS less then 5 years old; after 6 years of age a definite hyperglobulinemia of the IgG and IgA type was observed. A slight decrease in IgM was observed between 16 and 25 years of age. In subjects with DS lymphocyte phytohemagglutinin responsiveness was in the normal range during the first decade but it decreased thereafter progressively; the percentage and absolute number of peripheral blood lymphocytes forming "spontaneous rosettes" with sheep erythrocytes were abnormally low at all ages including infancy; the number of circulating lymphocytes with a high density of surface immunoglobulins was always in the normal range.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 11993318     DOI: 10.1002/eji.1830050904

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  Abnormal serum IgG subclass pattern in children with Down's syndrome.

Authors:  G Annerén; C G Magnusson; G Lilja; S L Nordvall
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

2.  Immunity in Down's syndrome.

Authors:  G R Burgio; A G Ugazio
Journal:  Eur J Pediatr       Date:  1978-04-20       Impact factor: 3.183

3.  Kinetics of 21-trisomic lymphocytes. I. In vitro response of 21-trisomic lymphocytes to PHA.

Authors:  A Serra; E Arpaia; R Bova
Journal:  Hum Genet       Date:  1978-03-17       Impact factor: 4.132

4.  Down syndrome: 130 years after its identification.

Authors:  L Nespoli
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

5.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

6.  Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy.

Authors:  N Fujii; K Oguma; M Fujii; R Fukatsu; N Takahata; M Kitabatake
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

7.  T cell response to anti-CD3 antibody in Down's syndrome.

Authors:  A Bertotto; C Arcangeli; S Crupi; I Marinelli; R Gerli; R Vaccaro
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

8.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

9.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.

Authors:  R Karttunen; T Nurmi; J Ilonen; H M Surcel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

Review 10.  Down syndrome and coeliac disease: five new cases with a review of the literature.

Authors:  M I Hilhorst; M Brink; E A Wauters; R H Houwen
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.